These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 12017270

  • 1. The effect of antiestrogens on TGF-beta-mediated chemotaxis of human breast cancer cells.
    Tong GM, Rajah TT, Zang XP, Pento JT.
    Anticancer Res; 2002; 22(1A):103-6. PubMed ID: 12017270
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of antiestrogens on the invasiveness and laminin attachment of breast cancer cells.
    Rajah TT, Pento JT.
    Cancer Invest; 1999; 17(1):10-8. PubMed ID: 10999044
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells.
    Abbas Abidi SM, Howard EW, Dmytryk JJ, Pento JT.
    Clin Exp Metastasis; 1997 Jul; 15(4):432-9. PubMed ID: 9219732
    [Abstract] [Full Text] [Related]

  • 11. Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7.
    Chiarenza A, Lazarovici P, Lempereur L, Cantarella G, Bianchi A, Bernardini R.
    Cancer Res; 2001 Apr 01; 61(7):3002-8. PubMed ID: 11306479
    [Abstract] [Full Text] [Related]

  • 12. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K, Su J, Trovitch PB.
    J Pharm Pharmacol; 2003 Aug 01; 55(8):1135-41. PubMed ID: 12956904
    [Abstract] [Full Text] [Related]

  • 13. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME, Katzenellenbogen BS.
    Cancer Res; 1994 Nov 15; 54(22):5867-74. PubMed ID: 7954416
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.
    Arrick BA, Korc M, Derynck R.
    Cancer Res; 1990 Jan 15; 50(2):299-303. PubMed ID: 2295070
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of predictive markers for vitamin D treatment.
    Christensen GL, Jepsen JS, Fog CK, Christensen IJ, Lykkesfeldt AE.
    Breast Cancer Res Treat; 2004 May 15; 85(1):53-63. PubMed ID: 15039597
    [Abstract] [Full Text] [Related]

  • 18. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X, Pisha E, Tonetti DA, Yao D, Li Y, Yao J, Burdette JE, Bolton JL.
    Chem Res Toxicol; 2003 Jul 15; 16(7):832-7. PubMed ID: 12870885
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.